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Ventricular Distribution pattern of 
the novel Sympathetic nerve pet 
Radiotracer 18F-LMI1195 in Rabbit 
Hearts
Rudolf A. Werner1,2,3, Hiroshi Wakabayashi3,4, Xinyu chen3,4, Nobuyuki Hayakawa3,4, 
constantin Lapa2,4,5, Steven P. Rowe1, Mehrbod S. Javadi1, Simon Robinson6 & 
takahiro Higuchi  2,4,7,8*
We aimed to determine a detailed regional ventricular distribution pattern of the novel cardiac nerve 
pet radiotracer 18F-LMI1195 in healthy rabbits. Ex-vivo high resolution autoradiographic imaging 
was conducted to identify accurate ventricular distribution of 18F-LMI1195. In healthy rabbits, 18f-
LMI1195 was administered followed by the reference perfusion marker 201tl for a dual-radiotracer 
analysis. After 20 min of 18F-LMI1195 distribution time, the rabbits were euthanized, the hearts were 
extracted, frozen, and cut into 20-μm short axis slices. Subsequently, the short axis sections were 
exposed to a phosphor imaging plate to determine 18F-LMI1195 distribution (exposure for 3 h). After 
complete 18F decay, sections were re-exposed to determine 201Tl distribution (exposure for 7 days). 
For quantitative analysis, segmental regions of Interest (ROIs) were divided into four left ventricular 
(LV) and a right ventricular (RV) segment on mid-ventricular short axis sections. Subendocardial, mid-
portion, and subepicardial ROIs were placed on the LV lateral wall. 18F-LMI1195 distribution was almost 
homogeneous throughout the LV wall without any significant differences in all four LV ROIs (anterior, 
posterior, septal and lateral wall, 99 ± 2, 94 ± 5, 94 ± 4 and 97 ± 3%LV, respectively, n.s.). Subepicardial 
201Tl uptake was significantly lower compared to the subendocardial portion (subendocardial, mid-
portion, and subepicardial activity: 90 ± 3, 96 ± 2 and *80 ± 5%LV, respectively, *p < 0.01 vs. mid-
portion). This was in contradistinction to the transmural wall profile of 18F-LMI1195 (90 ± 4, 96 ± 5 and 
84 ± 4%LV, n.s.). A slight but significant discrepant transmural radiotracer distribution pattern of 201tl in 
comparison to 18F-LMI1195 may be a reflection of physiological sympathetic innervation and perfusion 
in rabbit hearts.
On a subcellular level, alterations of the myocardial sympathetic nervous system (SNS) in Heart Failure (HF) 
patients are predominantly driven by cardiac norepinephrine (NE) spillover1. This phenomenon provokes severe 
damage to cardiac myocytes, mainly by AMP-mediated calcium overload, and is caused by either elevated plasma 
concentration of NE, an impaired function of the NE transporter (NET, uptake-1), or reduced plasma clearance of 
NE in the synaptic cleft1,2. Recent years have witnessed the more expanded use of cardiac SNS-based imaging uti-
lizing such NET ligands for either single photon emission computed tomography (SPECT) or positron emission 
tomography (PET) technology, which both allow for a thorough evaluation of sympathetic neurotransmission in 
HF patients3–9.
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Comparable to their physiological counterpart, those radiolabeled analogs of NE share similar pathways and 
are also taken up by the uptake-1 mechanism, which clears exocitotically released NE from the synaptic cleft3. 
In the last decade, several cardiac PET radiotracers have been demonstrated to precisely reflect sympathetic 
nerve integrity in a clinical setting: The prospective Prediction of ARrhythmic Events with Positron Emission 
Tomography (PAREPET) trial showed that the neuronal SNS PET agent 11C-Hydroxyephedrine (11C-HED) 
identifies HF patients who are at highest risk for sudden cardiac arrest or death10. While 11C-HED has been 
extensively used to investigate cardiac sympathetic nerve conditions, its high cost and the necessity of staff to 
prepare such short-half-life radiopharmaceuticals limit its widespread adoption3. This is in contradistinction to 
18F-labeled SNS radiotracers, such as 18F-LMI1195, which do not require costly on-site preparation due to the 
longer half-life of 18F (110 min). Thus, dispatch from central cyclotron facilities, even by commercial vendors, is 
feasible and such an approach has been proven to be profitable for the most commonly used oncology imaging 
agent, 2-deoxy-2-18F-fluoro-d-glucose3,11.
Moreover, in a recently published phase-2 study, 18F-LMI1195 demonstrated superior kinetics compared to 
11C-HED, in particular for early imaging time-points. Thus, a phase-3 trial in ischemic cardiomyopathy patients 
scheduled to receive an implantable cardioverter defibrillator (ICD) is underway and may further corroborate 
the potential benefit of 18F-LMI1195 for risk stratification12. However, if this PET agent will one day be routinely 
available in the clinic to help identify high-risk patients and support clinical decision-making, a more precise 
understanding of the subcellular radiotracer handling may be fundamentally necessary for the interpretation of 
imaging results. Notably, previous studies have already proven the high affinity of 18F-LMI1195 towards neuronal 
uptake-1 along with a stable storage in presynaptic vesicles13,14. However, further insights into the normal regional 
ventricular distribution of such radiotracers are essential for designing clinical protocols and comprehension of 
imaging findings. Thus, in the present study, we aimed to elucidate the distribution pattern of 18F-LMI1195 over 
the left ventricular (LV) wall in healthy rabbits.
Material and Methods
Animal protocols were approved by the local Animal Care and Use Committee (National Cardiovascular and 
Cerebral Research Center, Suita, Japan) and conducted according to the Guide for the Care and Use of Laboratory 
Animals (NIH Publication No. 85-23, revised 1996)15.
Radiopharmaceuticals. 18F-LMI1195 was synthesized following described procedures16,17. Analyses at the 
end of syntheses revealed specific radioactivity greater than 100 GBq/μmol and radiochemical purity greater than 
95% for the radiolabeled compound.
Dual-radiotracer autoradiography. In healthy New Zealand White rabbits weighing 3.8–4.2 kg (n = 4), 
ex-vivo high resolution autoradiographic imaging was conducted to determine accurate ventricular distribution 
of 18F-LMI1195. As a reference, the myocardial perfusion marker 201Tl was co-injected for dual-tracer analysis. 
18F-LMI1195 (25 MBq) was injected via ear vein followed by 201Tl (0.5 MBq). Rabbits were euthanized 20 min 
after 18F-LMI1195 administration, and the heart was removed. The heart was sliced into 20 μm thickness slices 
for autoradiographic analysis. The short axis sections were exposed to a phosphor imaging plate (MultiSensitive 
phosphor screen; PerkinElmer, Shelton, CT) to determine 18F-LMI1195 distribution (exposure for 3 h) with a 
digital autoradiography system (CR 35 Bio, Raytest or Cyclone; Packard; Straubenhardt, Germany). After com-
plete 18F decay of 3 days, sections were again re-exposed to determine 201Tl distribution (second exposure for 7 d). 
Figure 1 displays the described experimental setup.
Quantitative analysis. In order to quantify radiotracer uptake distribution, regions of interest (ROIs) were 
drawn on four left ventricular (LV) segments and a right ventricular (RV) segment on a mid-ventricular short axis 
section. To assess the transmural pattern of radiotracer distribution in the ventricular wall, the ROIs were divided 
into subepicardial, mid-portion, and subendocardial wall portions on the slices18.
Statistical analysis. Results are presented as means ± standard deviation (SD). The two-tailed paired 
Student’s t-test was used to compare differences between two dependent groups and the two-tailed independent 
Student’s t-test between independent groups. Values of p < 0.05 were considered statistically significant.
Figure 1. Schematic diagram illustrating the protocol for the dual-radiotracer autoradiography analysis using 
18F-LMI1195 and 201Tl.
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Results
Assessment of 18F-LMI1195 distribution throughout the LV Wall. 18F-LMI1195 distribution was 
homogeneous throughout the LV wall and no significant differences in radiotracer activity were detected in all 
short axis LV ROIs (anterior, posterior, septal and lateral walls, 99 ± 2, 94 ± 5, 94 ± 4 and 97 ± 3%LV, n.s.).
comparison of ventricular distribution patterns for both radiotracers. 201Tl uptake in the subepi-
cardial portion was significantly lower than in the subendocardial portion (subendocardial, mid-portion and sub-
epicardial activity: 90 ± 3, 96 ± 2 and *80 ± 5%LV, respectively, *p < 0.01 vs. mid-portion). Those findings were in 
contradistinction to the cardiac SNS radiotracer: 18F-LMI1195 demonstrated no significant differences between 
the three portions (90 ± 4, 96 ± 5, and 84 ± 4%LV, respectively, n.s.). Representative cross-sectional short-axis 
images at a midventricular level on dual-radiotracer autoradiography with 18F-LMI1195 and 201Tl are displayed 
in Fig. 2A. The ventricular distribution patterns for 18F-LMI1195 and 201Tl are highlighted in a transmural wall 
line profile (from endo- to epicardial wall portions, Fig. 2B): a decline in radiotracer activity for the reference 
perfusion marker at the epicardial section can be appreciated, while 18F-LMI1195 remained stable over all three 
wall portions.
Discussion
The present study investigated the transmural distribution pattern of the novel SNS imaging agent 18F-LMI1195 
in comparison to myocardial perfusion assessed by 201Tl in healthy rabbits. Using ex vivo high resolution auto-
radiographic imaging, which is free from in vivo imaging artifacts (e.g., motion, attenuation, and partial volume 
effect), a slight but significant discrepant transmural radiotracer distribution pattern of the perfusion agent in 
comparison to 18F-LMI1195 was noted: 201Tl uptake in the subepicardial section was significantly lower than 
subendocardial, while the SNS agent demonstrated no significant differences over all three wall portions.
The prospective PAREPET trial demonstrated that denervated myocardium assessed by 11C-HED serves as a 
strong outcome predictor for sudden cardiac arrest or death in high-risk HF patients10. However, owing to their 
short half-life, such 11C-labeled radiotracers suffer from several drawbacks. These include, but are not limited to 
a potential cold-mass effect (decrease of NE re-uptake function at higher amount of cold mass), the need for a 
costly on-site cyclotron, and the necessity for expert staff to prepare such radiopharmaceuticals3,4. Thus, novel 
18F-labeled radiotracers for mapping cardiac nerve integrity, such as 18F-LMI1195, may overcome these hurdles: 
their longer half-life may allow for radiotracer distribution from central cyclotron facilities and flexibility in study 
design, e.g., by facilitating delayed imaging protocols7.
An extensive body of evidence has reported on the high affinity of 18F-LMI1195 for neuronal uptake-1 includ-
ing cell-membrane binding assays and in vitro blocking studies with the potent uptake-1 blocker desipramine13,14. 
In addition, a desipramine chase protocol (delivery after radiotracer injection) led to no increased radiotracer 
Figure 2. (A) Representative cross-sectional short-axis images at a midventricular level on dual-radiotracer 
autoradiography with 18F-LMI1195 and 201Tl. 18F-LMI1195 distribution was homogeneous throughout the left 
ventricular wall and no significant differences in radiotracer activity were detected in mid-ventricular short 
axis slices. This is in contradistinction to the autoradiography (ARG) of 201Tl: A slight discrepant uptake pattern 
in the subepicardial wall portion can be appreciated compared to 18F-LMI1195 ARG. (B) Transmural wall line 
profile of both 18F-LMI1195 and 201Tl. The macroscopic findings were further corroborated quantitatively: 
Compared to the subendocardial wall section, radiotracer activity for 201Tl was significantly lower in the 
subepicardial wall portion. 18F-LMI1195 remained stable over all three section (subendocardial portion, mid-
portion, and subepicardial portion).
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washout, which indicates stable storage in presynaptic nerve terminals. Those findings were further confirmed in 
NE-expressing, vesicle-poor and vesicle-rich cell lines as well as in an isolated perfused rabbit heart setup using 
electric field stimulation (as vesicle turnover stimulant)13,19. Altogether, 18F-LMI1195 is taken up via uptake-1 
and stably stored inside presynaptic vesicles and thus, this catecholamine analogue closely mimicks physiolog-
ical NE turnover. Adding to those previous described findings, the present study provides further insight into 
the ventricular distribution of 18F-LMI1195 over the LV wall: ex vivo high resolution autoradiographic imaging 
demonstrated not only homogeneous radiotracer distribution in the LV, but also no significant differences in 
subendocardial, mid-portion, and subepicardial activity. Thus, the transmural wall line profile of 18F-LMI1195 
further corroborates a precise reflection of cardiac sympathetic neurotransmission with this radiotracer. Notably, 
all of those previously mentioned studies investigating 18F-LMI1195 in a preclinical setting have been conducted 
using rabbit myocardium: similar to the human heart, NE clearance through neuronal uptake-1 is also pro-
nounced in the rabbit heart. While extrapolations from animals to humans have to be made with caution, the rab-
bit myocardium may provide a reliable platform to investigate 18F-LMI1195 radiotracer distribution, as it closely 
mimicks human cardiac nerve integrity20. The findings in this study may, therefore, have direct applicability to 
the clinical setting.
In a transient myocardial ischemia model using Wistar rats, a higher susceptibility of cardiac sympathetic 
neurons compared to cardiomyocytes was demonstrated: in a head-to-head comparison of 201TI and 11C-HED, 
a larger defect for the latter radiotracer was noted and such uptake defect areas corresponded to the histolog-
ically identified regions of denervation. In addition, partial re-innervation in the chronic phase was demon-
strated (shown by recovery of subepicardial 11C-HED uptake), while no such findings were observed for 201TI18. 
Further adding to the complexity of this phenomenon, post-infarction sympathetic neuronal damage in humans 
assessed by 123I-metaiodobenzylguanidine (123I-mIBG) also exceeded the infarct size (assessed by 99mTc-sestamibi 
SPECT)21. In a prospective setting, Nishisato et al. enrolled 160 patients with consecutive ICDs and compared the 
myocardial SNS conditions using 123I-mIBG to myocardial perfusion alterations with 99mTc-tetrofosmin. This 
constituted a combined assessment of cardiac nerve and perfusion status and was of superior benefit in predicting 
ICD discharge rate than one imaging test alone22. Estorch et al. reported that in patients who developed angina 
during exercise test, the area of denervated but perfused myocardium was significantly larger than in subjects 
without angina23. Matsunari and coworkers reported similar findings: Sympathetic neuronal damage measured 
by 123I-mIBG was larger than the infarct size assessed by perfusion imaging, suggesting higher susceptibility of 
sympathetic neurons compared to cardiac myocytes21. Integrating those available data, the precise assessment of 
the transmural wall line profile of different cardiac nerve radiotracers compared to perfusion references in both 
healthy and impaired myocardium are of value. Thus, if a more widespread adoption of such dual-radiotracer 
approaches is to be pursued in a clinical setting in the near future, the properties of 18F-LMI1195 described in 
this manuscript may be of importance for interpreting imaging results of perfusion status and cardiac neuro-
transmission in the failing heart. In the present study, no in vivo PET study has been carried out. However, pre-
vious investigations have already proven the feasibility of in-vivo 18F-LMI1195 PET imaging using the identical 
animal model of New Zeland Rabbits and in humans14,17. Apart from that, the herein obtained results may lay 
the groundwork to study both cardiac nerve integrity and myocardial perfusion in dedicated animal models of 
myocardial ischemia, preferably by using an 18F-labeled SNS imaging agent like LMI1195.
conclusions
In healthy rabbits, a significant discrepant transmural radiotracer distribution pattern of 201Tl in comparison to 
18F-LMI1195 may be a reflection of physiological cardiac sympathetic innervation and perfusion. If 18F-LMI1195 
will one day be routinely available in the clinic, the herein presented distinct characteristics in the LV distribution 
pattern of perfusion status and cardiac nerve integrity may lay the groundwork for a more thorough evaluation 
of imaging results.
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